Figure 4.

The clinical outcome of HAGE protein expression in high risk oestrogen receptor negative (ER-) primary early breast cancer (PE-BC). (A–C) Kaplan–Meier curves showing the relationship between HAGE expression and breast cancer-specific survival (BCSS) and disease-free survival (DFS) in primary oestrogen receptor-negative breast cancer (PER-BC), stratified according to the received adjuvant chemotherapy protocols. (A) Whole cohort, (B) no chemotherapy/or less effective CMF and (C) anthracycline combination therapy (ACT). See text for details.